Pharmafile Logo
Pharmafocus logo
Advanced Search

PMCPA

Showing 15 posts of 81 posts found.

Vitor pharma image

Vifor ad breaches Code

November 26, 2012
Sales and Marketing ABPI, PMCPA, Vifor, ferinject

Vifor has been blasted after failing to adhere to an earlier ruling made under the ABPI’s Code of Practice. Such …

News
Revolade image

GSK guilty of off-label promotion

November 9, 2012
Medical Communications, Sales and Marketing GSK, PMCPA, Revolade

GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …

News
lilly corporate hq image

Lilly censured for rep photo

October 25, 2012
Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly

Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …

News
Merz image

Merz Pharma slammed by PMCPA

September 21, 2012
Medical Communications, Sales and Marketing ABPI, Merz Pharma, PMCPA

Merz Pharma UK has been rapped over the knuckles for three of the most serious breaches it is possible to …

News

Sanofi cleared in sales row

September 20, 2012
Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi

Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …

News
Cream advert image

Genus reprimanded for ‘sexual and titillating’ advert

August 15, 2012
Sales and Marketing ABPI, Genus, PMCPA, breach, eczema

Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News
Tapentadol

Grünenthal and Vifor breach Code

July 20, 2012
Sales and Marketing ABPI, Grunenthal, PMCPA, Vifor, code, tapentadol

Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …

News

PMCPA reprimands Chiesi for multiple breaches

June 18, 2012
Sales and Marketing COPD, Chiesi, GSK, PMCPA, code

Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …

News

Code of Practice update to reflect legal changes

May 11, 2012
Medical Communications ABPI, Code of Practice, MHRA, PMCPA, patient organisations

The UK pharma industry’s Code of Practice is set to be updated to bring it into line with changes in …

News

ABPI to help pharma with digital communications

May 4, 2012
Medical Communications ABPI, Code breach, PMCPA, Shire, digital, pharma

The ABPI has set up a new group to help pharma with its online communications.  The UK industry body said …

News
Shire's Vpriv website

Shire’s Vpriv website in breach of ABPI Code

April 24, 2012
Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct.  The complaint was …

News
Boehringer building image

Trajenta article lands Boehringer in hot water

March 19, 2012
Sales and Marketing ABPI Code, PMCPA, Trajenta, breach, diabetes

Boehringer Ingelheim has been publicly reprimanded for multiple breaches of the ABPI Code of Practice. In total the manufacturer fell …

News
Pradaxa image

Boehringer censured over Pradaxa website

March 8, 2012
Medical Communications ABPI, Boehringer Ingelheim, PMCPA, Pradaxa

Boehringer Ingelheim has breached the ABPI’s Code of Conduct over the use of its Pradaxa website.    Pradaxa is a …

News
Twitter logo

Watchdog frowns on Botox tweet

February 15, 2012
Medical Communications Allergan, Chugai, PMCPA, Twitter

Allergan have been found in breach of the UK Code of Practice after an employee used Twitter to communicate about …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024